Vitamin D alleviates indoxyl sulfate-induced inflammatory and cholesterol dysregulation in macrophages: Implications for vascular health in patients receiving hemodialysis
Kyoung Hye Kong, Kyungwon Yang, Jung-Hwa Ryu · 2026
Read Vitamin D alleviates indoxyl sulfate-induced inflammatory and cholesterol dysregulation in macrophages: Implications for vascular health in patients receiving hemodialysis by Kyoung Hye Kong, Kyungwon Yang, Jung-Hwa Ryu (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0357984.txt.
Description
Kyoung Hye Kong, Kyungwon Yang, and Jung-Hwa Ryu published a 2026 cell study in PLOS ONE on a gut-made toxin that builds up in kidney failure. The toxin damages blood vessels in dialysis patients. The toxin, indoxyl sulfate, drives inflammation in macrophages, the immune cells that also manage cholesterol. Because kidney patients are often short of vitamin D, the team pretreated lab macrophages with its active form before exposing them to the toxin.
Vitamin D pretreatment calmed several inflammatory signals the toxin provoked and raised markers of the calmer, repair-style macrophage state. It also protected the cells' ability to unload cholesterol through their usual transporter channels, which the toxin otherwise disrupts and which matters for keeping vessel walls clear. Active vitamin D may defend vessel health in dialysis patients on two fronts, inflammation and cholesterol handling, though the work is so far only in cultured cells.
Catalog record
| CREATOR | Kyoung Hye Kong, Kyungwon Yang, Jung-Hwa Ryu |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 44278 |
| LICENSE | CC_BY |
| RIGHTS | CC BY |
| SOURCE | PLOS |